Picture of GSK logo

GSK GSK News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

REG - GSK PLC - Publication of 2023 AGM Notice

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230327:nRSa3438Ua&default-theme=true

RNS Number : 3438U  GSK PLC  27 March 2023

GSK plc

(the 'Company')

 

Publication of Notice of Annual General Meeting 2023

 

The Company has today published on its website
(www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/
(http://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/)
) the Notice of Annual General Meeting ('AGM') 2023 (the '2023 AGM Notice'),
which will be distributed to shareholders shortly.

 

The Company's AGM will be held on Wednesday 3 May 2023 at 2.30pm at the
Sofitel London Heathrow, Terminal 5, London Heathrow Airport, TW6 2GD and will
also be broadcast live for shareholders to join electronically. Full details
of how to join the meeting either in person or electronically are contained in
the 2023 AGM Notice and AGM Guide.

In compliance with Listing Rule 9.6.1R of the UK Financial Conduct Authority,
the 2023 AGM Notice and Proxy Form for the AGM will be submitted to the UK
Listing Authority and will, in due course, be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

V A Whyte

Company Secretary

 

27 March 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOADZGZFMNNGFZM

Recent news on GSK

See all news